TrialDiabetes, obesity & metabolism2021

Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes.

Kirsten Dahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.